Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: Patients will be divided into four groups based on the random blood sugar level at the time of admission to covid ICU
Group A: Patients whose random blo
Sponsors
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: - Patient who had a covid-19 disease - Patients more than 18 years. - Patients of either sex. - Patients who are admitted in the covid-19 intensive care unit.
Exclusion criteria
Exclusion criteria: - Patients who is a known case of diabetes mellitus - Patients with pre-existing cardiac, liver, kidney diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - To assess the association between the random blood sugar level and mortality in critically ill covid-19 patients. Timepoint: - To assess the association between the baseline random blood sugar level of covid patients at the time of admission to covid ICU and mortality. | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe any other complications occurring in critically ill covid-19 patients with hyperglycemia.Timepoint: To observe any other complications occurring in critically ill covid-19 patients with hyperglycemia during their stay in covid icu. | — |
Countries
India
Contacts
Public ContactRajani Thabah
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
Outcome results
None listed